413 related articles for article (PubMed ID: 99746)
1. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
Hechtman P; Gordon BA; Ng Ying Kin NM
Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
[TBL] [Abstract][Full Text] [Related]
5. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
Conzelmann E; Sandhoff K
Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
[TBL] [Abstract][Full Text] [Related]
6. Purification, biochemical and immunological characterisation of hexosaminidase A from variant AB of infantile GM2 gangliosidosis.
Conzelmann E; Sandhoff K; Nehrkorn H; Geiger B; Arnon R
Eur J Biochem; 1978 Mar; 84(1):27-33. PubMed ID: 25769
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
Conzelmann E; Sandhoff K
Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
[TBL] [Abstract][Full Text] [Related]
8. Plasma G
Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
[TBL] [Abstract][Full Text] [Related]
9. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
Conzelmann E; Burg J; Stephan G; Sandhoff K
Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
Pullarkat RK; Reha H; Beratis NG
Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
[TBL] [Abstract][Full Text] [Related]
11. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
Hirabayashi Y; Li YT; Li SC
J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
13. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel.
Ishikawa Y; Li SC; Wood PA; Li YT
J Neurochem; 1987 Mar; 48(3):860-4. PubMed ID: 2949061
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
Hechtman P
Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
[TBL] [Abstract][Full Text] [Related]
15. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.
Sonderfeld S; Conzelmann E; Schwarzmann G; Burg J; Hinrichs U; Sandhoff K
Eur J Biochem; 1985 Jun; 149(2):247-55. PubMed ID: 3922757
[TBL] [Abstract][Full Text] [Related]
16. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
Erzberger A; Conzelmann E; Sandhoff K
Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
[TBL] [Abstract][Full Text] [Related]
17. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
18. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
[TBL] [Abstract][Full Text] [Related]
19. Canine GM2-gangliosidosis: chemical and enzymatic features.
Eto Y; Autilio-Gambetti L; McGrath JT
Adv Exp Med Biol; 1984; 174():431-40. PubMed ID: 6234761
[TBL] [Abstract][Full Text] [Related]
20. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein.
Mahuran DJ
Biochim Biophys Acta; 1998 Jul; 1393(1):1-18. PubMed ID: 9714704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
